Oxford Nanopore Technologies, a leading innovator in the field of DNA and RNA sequencing, has secured an impressive $50 million in funding aimed at further advancing its groundbreaking technology. Founded in 2005 as a spin-out from the University of Oxford, the company has revolutionized biological analysis with the world’s first and only nanopore sequencing platform. Unlike traditional methods, Oxford Nanopore's technology delivers real-time data, enabling users to conduct analyses on a scale ranging from pocket-sized devices to population-scale projects. This funding will play a pivotal role in expanding the development of their portable devices and enhancing their capacity for ultra-high throughput formats, ultimately aiding researchers and healthcare providers in over 100 countries. The company is dedicated to democratizing access to biological data, empowering anyone, anywhere, to conduct critical analyses that could lead to significant societal benefits. Under the leadership of CEO Dr. Gordon Sanghera, Oxford Nanopore is poised to disrupt conventional approaches to sequencing, opening new doors in genomics, transcriptomics, and diagnostic applications. As they embark on this next phase of growth, the company is committed to fostering innovation and harnessing the power of their technology to provide rapid, actionable insights that can drive advancements in healthcare and beyond. With this substantial investment, Oxford Nanopore is positioned not only to enhance its technological capabilities but also to solidify its leadership role in shaping the future of biomedicine and genomics globally.
Nanopore Sequencing Pioneer Oxford Nanopore Technologies Secures $50 Million in Funding for Revolutionary Biotechnology Platform
Get the full Oxford Nanopore Technologies company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Digital Asset
Digital Asset is a leading innovator in blockchain technology, transforming traditional and digital financial markets with privacy-enabled solutions that improve capital flow and create a more efficient, fair, and resilient global system. As the creator of the technology that launched the Canton Network, the only public layer one blockchain with privacy, and a founding member of its Global Synchronizer Foundation, Digital Asset has been a pioneer of this open, secure, and interoperable infrastructure. Founded in 2014, Digital Asset is committed to reshaping the future of finance by enabling real-time efficiencies, 24/7 global transactions, and unlocking the full potential of cryptocurrencies, digital assets, and the continued convergence of decentralized and traditional finance. In 2025, Digital Asset was included as a Unicorn in the World Economic Forum’s prestigious Innovator Communities.
$300.0M Unknown
today
White Circle
White Circle is the control layer for AI in production. We help companies test, protect, observe, and improve every AI interaction — from blocking unsafe inputs and preventing jailbreaks to analyzing user behavior and optimizing model performance.
$11.0M Seed
today
Hoplon AI
Human Convesation, Super Human Protection - Always on
$1.0M Seed
today
Isomorphic Labs
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease
$2.1B Series b
today
Sensible Medical Innovations Ltd.
Sensible Medical has developed a non-invasive fluid status monitor (ReDS) for accurate measurement and monitoring of lung fluid for heart failure patients.
$20.0M Unknown
today